Kimberly Clark Corp (KMB) Stock Analysis and Metrics

Kimberly Clark

NASDAQ: KMB

$111.45 ▲ +1.75 (+1.60%)

At close: Jul 27, 2026 · 3:59 PM UTC

Financial Ratios

Market Cap36.96 Bn

P/E92.87

P/S2.23

Div. Yield0.00

ROIC (Qtr)0.01

Total Debt (Qtr)7.08 Bn

Revenue Growth (1y) (Qtr)2.69

Add ratio to table…

About

Kimberly-Clark Corporation is a global company focused on delivering products and solutions that provide better care for a better world. The company manufactures and sells personal care and consumer goods under well-known brands such as Kleenex, Scott, Huggies, Pull-Ups, Kotex and Depend. Its operations span manufacturing facilities in 30 countries including equity affiliates, with products sold in more than 175 countries and territories. The company's core business centers on essential hygiene and health-related products for consumers worldwide.

Kimberly-Clark Corporation generates revenue primarily through the sale of its branded consumer products across categories including baby and child care, adult and feminine care, and professional products. Revenue is derived from product sales to retailers, distributors, and other commercial channels globally. The company's income streams are supported by its portfolio of trusted household brands that address everyday hygiene and wellness needs.

The company operates through the following segments: North America and International Personal Care.

• North America segment includes the sale of personal care products such as baby diapers, feminine hygiene items, adult incontinence products, and facial and bathroom tissues primarily within the United States and Canada.

• International Personal Care segment encompasses the same product categories sold outside of North America, serving markets in Europe, Asia, Latin America, and other international regions.

Kimberly-Clark Corporation holds a leading position in the global consumer goods industry, particularly in the personal care sector, where it competes with major multinational corporations such as Procter & Gamble and Unilever. The company maintains competitive advantages through its strong brand portfolio, extensive global distribution network, and ongoing investment in innovation and supply chain efficiency.

Kimberly-Clark Corporation serves a broad customer base that includes individual consumers purchasing through retail outlets, as well as institutional buyers such as hospitals, nursing homes, and commercial facilities that rely on its professional and healthcare-focused products.

Investment Thesis

▲ Bull case

Kimberly-Clark's underlying business momentum remains resilient and is being underestimated by the market, particularly in the International Personal Care (IPC) segment where organic sales grew 4.0% in Q1 driven by strong volume-led growth and enhanced portfolio mix from improved consumer value propositions. This performance was achieved despite ongoing geopolitical uncertainty and reflects the company's ability to execute consumer-inspired innovation and strong in-market execution across diverse international markets, including double-digit growth in Southeast Asia and Korea where a 6.5% birth increase fueled a 20% category surge and Kimberly-Clark maintains over 60% share. The company's focus on driving value across its good, better, best tiers—rather than competing solely on price—has allowed it to gain share in 95% of sales-weighted markets in North America and 84% internationally, indicating deep and broad-based brand strength that is not fully captured in headline organic growth figures.
The pending acquisition of Kenvue represents a significant but underappreciated strategic catalyst that could unlock generational value creation, with management emphasizing that the combined entity will leverage Kimberly-Clark's proven durable operating model to accelerate innovation and commercial execution. Despite recent execution challenges at Kenvue being widely reported, leadership views these as largely tactical rather than structural, noting pockets of strong profitable growth throughout the business and confidence in Kenvue's ability to improve this year after adopting an operating model consistent with Kimberly-Clark's market-centric balanced matrix approach. The integration process is already underway with over 40 teams working on synergies, including tangible logistics advantages such as combining Kimberly-Clark's bulky, light products with Kenvue's dense, small items to optimize truck utilization—a concrete example of immediate cost savings that are not yet reflected in financial guidance but could meaningfully enhance margins post-close.
Kimberly-Clark's financial discipline and cost management capabilities have significantly improved since prior commodity cycles, giving it greater resilience to offset potential input cost inflation than the market currently assumes. The company has delivered back-to-back 6% gross productivity for two years and is on track to maintain that rate in 2026, supported by a $2 billion North America supply chain investment progressing as planned and a rich pipeline of ongoing initiatives. Crucially, Kimberly-Clark has expanded both gross and operating profit margins beyond pre-pandemic levels from 2023 through 2025 despite facing approximately $200 million in input cost inflation annually during that period, demonstrating a proven track record of recovering costs through pricing net of cost discipline, revenue growth management, supplier hedging, and strategic supplier relationships—capabilities that position it to manage the potential $150-$170 million in gross incremental input costs from sustained $100 oil prices without derailing its margin expansion trajectory.

Kimberly-Clark's underlying business momentum remains resilient and is being underestimated by the market, particularly in the International Personal Care (IPC) segment where organic sales grew 4.0% in Q1 driven by strong volume-led growth and enhanced portfolio mix from improved consumer value propositions. This performance was achieved despite ongoing geopolitical uncertainty and reflects the company's ability to execute consumer-inspired innovation and strong in-market execution across diverse international markets, including double-digit growth in Southeast Asia and Korea where a 6.5% birth increase fueled a 20% category surge and Kimberly-Clark maintains over 60% share. The company's focus on driving value across its good, better, best tiers—rather than competing solely on price—has allowed it to gain share in 95% of sales-weighted markets in North America and 84% internationally, indicating deep and broad-based brand strength that is not fully captured in headline organic growth figures.
The pending acquisition of Kenvue represents a significant but underappreciated strategic catalyst that could unlock generational value creation, with management emphasizing that the combined entity will leverage Kimberly-Clark's proven durable operating model to accelerate innovation and commercial execution. Despite recent execution challenges at Kenvue being widely reported, leadership views these as largely tactical rather than structural, noting pockets of strong profitable growth throughout the business and confidence in Kenvue's ability to improve this year after adopting an operating model consistent with Kimberly-Clark's market-centric balanced matrix approach. The integration process is already underway with over 40 teams working on synergies, including tangible logistics advantages such as combining Kimberly-Clark's bulky, light products with Kenvue's dense, small items to optimize truck utilization—a concrete example of immediate cost savings that are not yet reflected in financial guidance but could meaningfully enhance margins post-close.
Kimberly-Clark's financial discipline and cost management capabilities have significantly improved since prior commodity cycles, giving it greater resilience to offset potential input cost inflation than the market currently assumes. The company has delivered back-to-back 6% gross productivity for two years and is on track to maintain that rate in 2026, supported by a $2 billion North America supply chain investment progressing as planned and a rich pipeline of ongoing initiatives. Crucially, Kimberly-Clark has expanded both gross and operating profit margins beyond pre-pandemic levels from 2023 through 2025 despite facing approximately $200 million in input cost inflation annually during that period, demonstrating a proven track record of recovering costs through pricing net of cost discipline, revenue growth management, supplier hedging, and strategic supplier relationships—capabilities that position it to manage the potential $150-$170 million in gross incremental input costs from sustained $100 oil prices without derailing its margin expansion trajectory.

▼ Bear case

Kimberly-Clark faces significant near-term margin pressure from unmitigated input cost inflation that could exceed current expectations, particularly as the company has not built the potential $150-$170 million in gross incremental costs from sustained $100 oil prices into its outlook and has yet to finalize specific mitigating actions. While management cites its integrated margin management framework and pricing net of cost discipline, the CFO acknowledged that teams are still in the process of renegotiating contracts and working through scenarios with suppliers, indicating that concrete offsetting measures are not yet in place. This is especially concerning given that the company is already operating at its targeted 6% productivity rate with limited headroom to increase it further, and any reliance on pricing or revenue growth management to offset costs risks disrupting the very volume and mix growth that has been innovation-driven and promotion-supported—potentially undermining the core engine of its recent performance.
The company's organic sales growth is being flattered by temporary tailwinds that may not persist, creating a risk of overestimation in the sustainability of its current momentum. North America organic sales growth of 1.8% in Q1 was partially driven by strong activation programming that anticipated demand through December shipments, a timing-related benefit that is not expected to repeat and contributed to the expectation of slightly below-Q1 organic growth in Q2 due to lapping the strongest quarter of the prior year (when North America volume grew 5%). Furthermore, the exit of the private label diaper business continues to create a headwind, with a 1.8% impact on total net sales in Q1 and an expected 50 basis point drag on full-year reported sales, meaning that underlying organic performance must overcome structural drags just to show flat top-line growth, a challenge that could intensify if consumer spending weakens amid persistent macroeconomic uncertainty.
Strategic execution risks surrounding major transformative initiatives are being underestimated, particularly regarding the Kenvue acquisition and the IFP joint venture with Suzano, both of which carry significant integration and regulatory uncertainties that could delay or diminish expected synergies. Although the UK watchdog has not referred the Suzano joint venture for a Phase 2 investigation and EU approval is expected unconditionally, the deal remains under investigation by the CMA with a decision due May 28, creating near-term uncertainty over timing and structure. Simultaneously, while Kimberly-Clark expresses confidence in Kenvue's turnaround, the consumer health company recently beat estimates only in its skin health and beauty brands—suggesting uneven performance across its portfolio—and the integration of two large, complex organizations with overlapping go-to-market functions risks execution delays, cultural friction, and underestimated separation costs, all of which could impair the ability to realize the projected 40% increase in income from equity companies and undermine the bullish case for accelerated EPS growth.

Kimberly-Clark faces significant near-term margin pressure from unmitigated input cost inflation that could exceed current expectations, particularly as the company has not built the potential $150-$170 million in gross incremental costs from sustained $100 oil prices into its outlook and has yet to finalize specific mitigating actions. While management cites its integrated margin management framework and pricing net of cost discipline, the CFO acknowledged that teams are still in the process of renegotiating contracts and working through scenarios with suppliers, indicating that concrete offsetting measures are not yet in place. This is especially concerning given that the company is already operating at its targeted 6% productivity rate with limited headroom to increase it further, and any reliance on pricing or revenue growth management to offset costs risks disrupting the very volume and mix growth that has been innovation-driven and promotion-supported—potentially undermining the core engine of its recent performance.
The company's organic sales growth is being flattered by temporary tailwinds that may not persist, creating a risk of overestimation in the sustainability of its current momentum. North America organic sales growth of 1.8% in Q1 was partially driven by strong activation programming that anticipated demand through December shipments, a timing-related benefit that is not expected to repeat and contributed to the expectation of slightly below-Q1 organic growth in Q2 due to lapping the strongest quarter of the prior year (when North America volume grew 5%). Furthermore, the exit of the private label diaper business continues to create a headwind, with a 1.8% impact on total net sales in Q1 and an expected 50 basis point drag on full-year reported sales, meaning that underlying organic performance must overcome structural drags just to show flat top-line growth, a challenge that could intensify if consumer spending weakens amid persistent macroeconomic uncertainty.
Strategic execution risks surrounding major transformative initiatives are being underestimated, particularly regarding the Kenvue acquisition and the IFP joint venture with Suzano, both of which carry significant integration and regulatory uncertainties that could delay or diminish expected synergies. Although the UK watchdog has not referred the Suzano joint venture for a Phase 2 investigation and EU approval is expected unconditionally, the deal remains under investigation by the CMA with a decision due May 28, creating near-term uncertainty over timing and structure. Simultaneously, while Kimberly-Clark expresses confidence in Kenvue's turnaround, the consumer health company recently beat estimates only in its skin health and beauty brands—suggesting uneven performance across its portfolio—and the integration of two large, complex organizations with overlapping go-to-market functions risks execution delays, cultural friction, and underestimated separation costs, all of which could impair the ability to realize the projected 40% increase in income from equity companies and undermine the bullish case for accelerated EPS growth.

Segments Breakdown of Revenue (2025)

Peer Comparison

Companies in the Household & Personal Products

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	PG	PROCTER & GAMBLE Co	345.95 Bn	20.73	3.99	37.03 Bn
2	UL	Unilever Plc	134.07 Bn	28.26	4.05	32.92 Bn
3	CL	Colgate Palmolive Co	73.64 Bn	33.24	3.54	7.94 Bn
4	KVUE	Kenvue Inc.	37.28 Bn	22.98	2.44	8.66 Bn
5	KMB	Kimberly Clark Corp	36.96 Bn	92.87	2.23	7.08 Bn
6	EL	Estee Lauder Companies Inc	30.06 Bn	-157.40	2.03	7.31 Bn
7	CHD	Church & Dwight Co Inc /De/	23.36 Bn	24.96	418.62	2.40 Bn
8	CLX	Clorox Co /De/	11.85 Bn	15.38	1.75	2.49 Bn

Research Tools

Developers

About

Investment Thesis

Product and Service Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Product and Service Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer Comparison

Create an account

Sign In

Reset Password